Aimei Health Technology Unit (AFJKU) vs Southern Cross Acquisition II - (SCAT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Head-to-head
| Metric | AFJKU | SCAT |
|---|---|---|
| Share price | $13.50 | $9.88 |
| Market cap | — | $75.57M |
| 1-day change | 0.00% | +0.05% |
| YTD return | -79.55% | — |
| 1-year return | +20.00% | — |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $80.00 | $9.95 |
| 52-week low | $7.60 | $9.87 |
| Distance from 52-week high | -83.13% | -0.75% |
| Average volume | 1.08K | 124.90K |
| Shares outstanding | — | 7.65M |
| Sector | Financial Services | Financial Services |
| Industry | Shell Companies | Shell Companies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Aimei Health Technology Unit
AFJKU stock →Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses.
Financial Services · Shell Companies
About Southern Cross Acquisition II -
SCAT stock →Southern Cross Acquisition II Corp. focuses on effecting into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses.
Financial Services · Shell Companies
AFJKU vs SCAT FAQ
Are Aimei Health Technology Unit and Southern Cross Acquisition II - in the same industry?
Yes. Both are classified in the Shell Companies industry within the Financial Services sector.